Ibract

Palbociclib

Category:

Chemical

Chemical

Oral

Oral

Dosage form :

Capsules

Doses :

75/100/125 mg

Short Description:

Ibract is an anticancer medicine containing the active substance palbociclib. Palbociclib works by blocking proteins called cyclin-dependent kinase 4 and 6, which regulate cell growth and division. Blocking these proteins can slow down growth of cancer cells and delay the progression of cancer.

Product Introduction

What Ibract is and what it is used for?

Ibract is an anticancer medicine containing the active substance Palbociclib.

Palbociclib works by blocking proteins called cyclin-dependent kinase 4 and 6, which regulate cell growth and division. Blocking these proteins can slow down growth of cancer cells and delay the progression of your cancer.

Ibract is used to treat patients with certain types of breast cancer (hormone receptor-positive, human epidermal growth factor receptor 2-negative) which have spread beyond the original tumour and/or to other organs. It is given together with aromatase inhibitors or fulvestrant, which are used as hormonal anticancer therapies.

Sunitinib

Chemical

Chemical

Oral

Oral

Zoledronic Acid

Chemical

Chemical

Injectable

Injectable

Everolimus

Chemical

Chemical

Oral

Oral